These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27651971)

  • 1. Severe Primary Raynaud's Disease Treated with Rituximab.
    Shabrawishi M; Albeity A; Almoallim H
    Case Rep Rheumatol; 2016; 2016():2053804. PubMed ID: 27651971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Raynaud's Phenomenon in the Patient with Connective Tissue Disease.
    Chatterjee S
    Curr Treat Options Cardiovasc Med; 2010 Apr; 12(2):185-204. PubMed ID: 20842555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficulties in diagnosis and treatment of severe secondary Raynaud's phenomenon in a Cameroonian woman: a case report.
    Agbor VN; Njim T; Aminde LN
    J Med Case Rep; 2016 Dec; 10(1):356. PubMed ID: 27998297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
    J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solvent-Induced Raynaud's Phenomenon.
    Rodrigues H; Reigota C; Teles C; Moreira S; Santos L
    Cureus; 2023 Sep; 15(9):e45004. PubMed ID: 37829986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.
    Anderson JE; Held N; Wright K
    Pediatrics; 2004 Apr; 113(4):e360-4. PubMed ID: 15060268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with bosentan and sildenafil for refractory digital ulcers and Raynaud's phenomenon in a 30-year-old woman with systemic sclerosis: Case report and literature review.
    Rademacher JG; Wincup C; Tampe B; Korsten P
    J Scleroderma Relat Disord; 2020 Jun; 5(2):159-164. PubMed ID: 35382024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raynaud's phenomenon and digital ischaemia--pharmacologic approach and alternative treatment options.
    Linnemann B; Erbe M
    Vasa; 2016; 45(3):201-12. PubMed ID: 27129065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiological profile of secondary Raynaud's phenomenon in an internal medicine department. About 121 patients].
    Ben Salem T; Tougorti M; Bziouech S; Lamloum M; Khanfir M; Ben Ghorbel I; Houman MH
    J Med Vasc; 2018 Feb; 43(1):29-35. PubMed ID: 29425538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iloprost infusion through elastomeric pump in the treatment of Raynaud's phenomenon and digital ulcers.
    Fartura Braga Temido MH; Gomes M; Parente F; Santos L
    J Scleroderma Relat Disord; 2019 Feb; 4(1):NP1-NP4. PubMed ID: 35382145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of severe Raynaud's Phenomenon secondary to autoimmune vasculopathy in a young woman.
    Amissah-Arthur MB; Wu LP
    Ghana Med J; 2021 Mar; 55(1):96-100. PubMed ID: 38322394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Raynaud's phenomenon in children].
    Quartier P
    Arch Pediatr; 2004 Jan; 11(1):74-7. PubMed ID: 14700771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon: from molecular pathogenesis to therapy.
    Prete M; Fatone MC; Favoino E; Perosa F
    Autoimmun Rev; 2014 Jun; 13(6):655-67. PubMed ID: 24418302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoscopic thoracic sympathicotomy for Raynaud's phenomenon.
    Matsumoto Y; Ueyama T; Endo M; Sasaki H; Kasashima F; Abe Y; Kosugi I
    J Vasc Surg; 2002 Jul; 36(1):57-61. PubMed ID: 12096258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Raynaud's phenomenon-A streamlined approach to acute management.
    Lee R; Lomas O; Handa A
    Int J Surg Case Rep; 2011; 2(4):61-3. PubMed ID: 26902555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis.
    Pope J; Fenlon D; Thompson A; Shea B; Furst D; Wells G; Silman A
    Cochrane Database Syst Rev; 2000; 1998(2):CD000953. PubMed ID: 10796395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial perfusion in peripheral Raynaud's phenomenon. Evaluation using stress cardiovascular magnetic resonance.
    Mavrogeni S; Bratis K; Koutsogeorgopoulou L; Karabela G; Savropoulos E; Katsifis G; Raftakis J; Markousis-Mavrogenis G; Kolovou G
    Int J Cardiol; 2017 Feb; 228():444-448. PubMed ID: 27870974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloproliferative Disease: An Unusual Cause of Raynaud's Phenomenon and Digital Ischaemia.
    Beynon C; Huws G; Lawson T
    Case Rep Med; 2016; 2016():9675171. PubMed ID: 27895669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Raynaud's phenomenon, disease or syndrome?].
    Fiessinger JN
    Rev Prat; 2011 Sep; 61(7):899-903. PubMed ID: 22039719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.